December 20, 2022
Life Sciences
  • CVS and Walgreens are limiting purchases of children’s pain-relief medicine amid rising cases of flu, COVID-19, and RSV. “Due to increased demand and various supplier challenges, over-the-counter pediatric fever reducing products are seeing constraint across the country,” Walgreens said in a statement, adding that the purpose of the limits is to support availability and avoid excess purchases. The Consumer Healthcare Products Association said sales of pediatric pain relievers are up 65 percent from this time last year. (Articles here, here, and here)